These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12218892)

  • 1. [Digestive manifestations in systemic sclerosis].
    Attar A
    Ann Med Interne (Paris); 2002 Jun; 153(4):260-4. PubMed ID: 12218892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal manifestations of progressive systemic sclerosis.
    Lock G; Holstege A; Lang B; Schölmerich J
    Am J Gastroenterol; 1997 May; 92(5):763-71. PubMed ID: 9149182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem.
    Ntoumazios SK; Voulgari PV; Potsis K; Koutis E; Tsifetaki N; Assimakopoulos DA
    Semin Arthritis Rheum; 2006 Dec; 36(3):173-81. PubMed ID: 17045629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects, pathophysiology, diagnosis and therapy of gastrointestinal manifestations of progressive systemic scleroderma].
    Folwaczny C; Voderholzer W; Riepl RL; Schindlbeck N
    Z Gastroenterol; 1996 Aug; 34(8):497-508. PubMed ID: 8967123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic sclerosis].
    Tamborrini G; Distler M; Distler O
    Med Monatsschr Pharm; 2008 May; 31(5):162-70; quiz 171-2. PubMed ID: 18552072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin].
    Lecomte T; Cavicchi M; Delchier JC
    Gastroenterol Clin Biol; 2000 Mar; 24(3):361-3. PubMed ID: 10804347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal features of scleroderma.
    Sjogren RW
    Curr Opin Rheumatol; 1996 Nov; 8(6):569-75. PubMed ID: 9018461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Digestive involvement of scleroderma].
    Ponge T; Bruley des Varannes S
    Rev Prat; 2002 Nov; 52(17):1896-900. PubMed ID: 12532866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal and small intestinal manifestations of progressive systemic sclerosis. A clinical and experimental study.
    Hendel L
    Dan Med Bull; 1994 Sep; 41(4):371-85. PubMed ID: 7813247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal motility disorders in scleroderma.
    Sjogren RW
    Arthritis Rheum; 1994 Sep; 37(9):1265-82. PubMed ID: 7945489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Digestive localizations of scleroderma].
    Modigliani R
    Ann Med Interne (Paris); 1984; 135(8):601-5. PubMed ID: 6529055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M; Varga J
    Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrition in systemic sclerosis.
    Recasens MA; Puig C; Ortiz-Santamaria V
    Reumatol Clin; 2012; 8(3):135-40. PubMed ID: 22197834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis].
    Savarino E; Ghio M; Marabotto E; Zentilin P; Sammito G; Cittadini G; Sconfienza L; Murolo C; Gemignani L; Indiveri F; Savarino V
    Recenti Prog Med; 2009 Nov; 100(11):512-6. PubMed ID: 20066883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal features in systemic sclerosis].
    Stelle M; Chizzolini C
    Rev Med Suisse; 2014 Apr; 10(426):860-3. PubMed ID: 24834644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases.
    Perlemuter G; Cacoub P; Chaussade S; Wechsler B; Couturier D; Piette JC
    Arthritis Rheum; 1999 Jul; 42(7):1545-9. PubMed ID: 10403284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Visceral scleroderma].
    Chomette G; Tranbaloc P; Beaufils H; Auriol M
    Ann Med Interne (Paris); 1984; 135(8):606-10. PubMed ID: 6529056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastrointestinal involvement in systemic sclerosis].
    Marie I
    Presse Med; 2006 Dec; 35(12 Pt 2):1952-65. PubMed ID: 17159722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic intestinal pseudoobstruction: report of four pediatric patients.
    Dalgiç B; Sari S; Doğan I; Unal S
    Turk J Gastroenterol; 2005 Jun; 16(2):93-7. PubMed ID: 16252200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global improvement of systemic scleroderma under long-term administration of octreotide.
    Descamps V; Duval X; Crickx B; Bouscarat F; Coffin B; Belaich S
    Eur J Dermatol; 1999 Sep; 9(6):446-8. PubMed ID: 10491499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.